Prediction of disease complication occurrence in Crohn's disease using phenotype and genotype parameters at diagnosis
Authors:
- Yoav MazorYMYoav Mazor
- Itay MazaIMItay Maza
- Eduard KaufmanEKEduard Kaufman
- Shomron Ben-HorinSBShomron Ben-Horin
- Amir KarbanAKAmir Karban
- Yehuda ChowersYCYehuda Chowers
- Rami EliakimRERami Eliakim
- 1 December 2011
- journal article
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 5 (6) , 592-597
Abstract
Complications associated with Crohn's disease (CD) are common and influence treatment decisions and outcomes. Appropriate early treatment may offer a therapeutic advantage to patients. The aim of our study was to indentify predictive factors for occurrence of complications at the time of CD diagnosis. The study population consisted of 269 CD patients treated during a ten year period. Risk factors compared between complicated and non-complicated disease included phenotypical characteristics, disease classification and the presence of NOD2/CARD15 mutations and single nucleotide polymorphisms in selected autophagy and phagosome genes. Complete data was obtained for 146 patients with an average follow up of 12years. Sixty five patients (44%) developed a complication during follow up. The only independent risk factors associated with developing a complication were smoking and male gender. There was no association between developing complications and the presence of selected SNPs (P=0.07 for Tyrosine residue on both alleles in NCF4 SNP rs4821544 and P=0.06 for a Guanine residue on both alleles in ATG16L SNP rs2241880). Multivariate analysis using a backwards logistic regression model left only male gender as an independent statistically significant association with complicated disease (OR 2.6017, 95% CI: 1.17 to 5.75). The median time to developing a complication was 4years, and the most common complication was the need for surgical intervention (54%). In the present study, a risk factor for developing CD complication was male gender. Further studies are warranted to assess additional risk factors and how such findings should affect therapy.Keywords
This publication has 36 references indexed in Scilit:
- Incidence and Risk of Intestinal and Extra-intestinal Complications in Medicaid Patients with Inflammatory Bowel Disease: A 5-Year Population-Based StudyDigestive Diseases and Sciences, 2010
- The Natural History of Adult Crohn's Disease in Population-Based CohortsAmerican Journal of Gastroenterology, 2010
- Concomitant Use of Immunomodulators with Anti-TNF in Crohns Disease: Yes or No?Current Drug Targets, 2010
- Perianal Disease Predicts Changes in Crohn's Disease Phenotype-Results of a Population-Based Study of Inflammatory Bowel Disease PhenotypeAmerican Journal of Gastroenterology, 2008
- Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trialThe Lancet, 2008
- Predictors of severe Crohn's diseaseScandinavian Journal of Gastroenterology, 2008
- Predictors of Crohn’s DiseaseGastroenterology, 2006
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2002
- A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's diseaseGastroenterology, 2000
- Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews.Gut, 1993